TSW
Thompson Siegel & Walmsley’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9M | Buy |
244,420
+7,393
| +3% | +$482K | 0.27% | 94 |
|
|
2025
Q1 | $15.9M | Sell |
237,027
-46,833
| -16% | -$3.14M | 0.27% | 92 |
|
|
2024
Q4 | $15.7M | Buy |
283,860
+53,701
| +23% | +$2.97M | 0.24% | 99 |
|
|
2024
Q3 | $13.7M | Buy |
230,159
+34,416
| +18% | +$2.05M | 0.2% | 109 |
|
|
2024
Q2 | $12.5M | Buy |
195,743
+2,986
| +2% | +$190K | 0.2% | 111 |
|
|
2024
Q1 | $13.3M | Sell |
192,757
-20,154
| -9% | -$1.39M | 0.2% | 109 |
|
|
2023
Q4 | $11.7M | Sell |
212,911
-15,796
| -7% | -$871K | 0.19% | 116 |
|
|
2023
Q3 | $13.3M | Sell |
228,707
-133,584
| -37% | -$7.76M | 0.22% | 101 |
|
|
2023
Q2 | $19.5M | Sell |
362,291
-31,498
| -8% | -$1.7M | 0.31% | 87 |
|
|
2023
Q1 | $15.6M | Sell |
393,789
-21,491
| -5% | -$854K | 0.25% | 96 |
|
|
2022
Q4 | $16.7M | Sell |
415,280
-682
| -0.2% | -$27.4K | 0.27% | 97 |
|
|
2022
Q3 | $13.4M | Sell |
415,962
-19,911
| -5% | -$640K | 0.23% | 109 |
|
|
2022
Q2 | $12.9M | Buy |
435,873
+11,786
| +3% | +$350K | 0.21% | 114 |
|
|
2022
Q1 | $11.9M | Buy |
424,087
+144,533
| +52% | +$4.06M | 0.17% | 134 |
|
|
2021
Q4 | $12.9M | Sell |
279,554
-170,950
| -38% | -$7.88M | 0.18% | 136 |
|
|
2021
Q3 | $14.8M | Buy |
450,504
+70,030
| +18% | +$2.3M | 0.21% | 115 |
|
|
2021
Q2 | $13.3M | Buy |
380,474
+51,935
| +16% | +$1.82M | 0.18% | 120 |
|
|
2021
Q1 | $11.9M | Sell |
328,539
-4,268
| -1% | -$154K | 0.17% | 127 |
|
|
2020
Q4 | $9.67M | Sell |
332,807
-4,231
| -1% | -$123K | 0.15% | 133 |
|
|
2020
Q3 | $9.51M | Buy |
337,038
+38,104
| +13% | +$1.07M | 0.18% | 119 |
|
|
2020
Q2 | $9.67M | Buy |
298,934
+294,992
| +7,483% | +$9.54M | 0.19% | 114 |
|
|
2020
Q1 | $161K | Buy |
+3,942
| New | +$161K | ﹤0.01% | 329 |
|